|
381 |
Nivolumab highly cost effective for renal cancer in Scotland
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 21
|
|
|
|
382 |
Nützliches für die Hausarztmedizin
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 12.9.2017, Nr. 15, date:9.2017: 3
|
|
|
|
383 |
Obesity increases economic burden of DM in the US
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 23
|
|
|
|
384 |
Observed drug expenditure lower than company estimate
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 24
|
|
|
|
385 |
OLT complications substantial financial burden
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 20
|
|
|
|
386 |
OnabotulinumtoxinA least costly option in OAB
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 21
|
|
|
|
387 |
OOP costs increase abandonment of antineoplastic prescriptions
Enthalten in PharmacoEconomics & outcomes news Bd. 794, 13.1.2018, Nr. 1, date:1.2018: 21
|
|
|
|
388 |
Optilog Plus
Enthalten in Experimental techniques Bd. 7, 20.12.2017, Nr. 1, date:1.1983: 37
|
|
|
|
389 |
Oral glucocorticoids increase risk and costs of AEs
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 22
|
|
|
|
390 |
Oral health behaviour in migrant and non-migrant adults in Germany: the utilization of regular dental check-ups
Enthalten in BMC oral health Bd. 17, 19.5.2017, Nr. 1, date:12.2017: 1-7
|
|
Administration
